Skip to content
Nedocromil
Alocril, Tilade (nedocromil) is a small molecule pharmaceutical. Nedocromil was first approved as Tilade on 1992-12-30. It is used to treat allergic conjunctivitis and pruritus in the USA.
Download report
Favorite
Commercial
Therapeutic Areas
Therapeutic Area
MeSH
eye diseasesD005128
skin and connective tissue diseasesD017437
immune system diseasesD007154
signs and symptoms pathological conditionsD013568
Trade Name
FDA
EMA
No data
Drug Products
FDA
EMA
New Drug Application (NDA)
New Drug Application (NDA)
Abbreviated New Drug Application (ANDA)
Abbreviated New Drug Application (ANDA)
Nedocromil sodium
Tradename
Company
Number
Date
Products
ALOCRILAllerganN-021009 DISCN1999-12-08
1 products, RLD
TILADEKing PharmaceuticalsN-019660 DISCN1992-12-30
1 products
TILADESanofiN-020750 DISCN1997-10-01
1 products
Hide discontinued
Labels
FDA
EMA
Brand Name
Status
Last Update
alocrilNew Drug Application2018-07-17
Indications
FDA
EMA
Indication
Ontology
MeSH
ICD-10
allergic conjunctivitisEFO_0007141D003233H10.44
pruritusHP_0000989D011537L29
Agency Specific
FDA
EMA
No data
Patent Expiration
No data
ATC Codes
R: Respiratory system drugs
R01: Nasal preparations
R01A: Decongestants and other nasal preparations for topical use
R01AC: Antiallergic nasal preparations for topical use, excl. corticosteroids
R01AC07: Nedocromil
R03: Drugs for obstructive airway diseases
R03B: Other drugs for obstructive airway diseases, inhalants in atc
R03BC: Antiallergic inhalants for obstructive airway diseases, excl. corticosteroids
R03BC03: Nedocromil
S: Sensory organ drugs
S01: Ophthalmologicals
S01G: Decongestants and antiallergics
S01GX: Other antiallergics in atc
S01GX04: Nedocromil
HCPCS
No data
Clinical
Clinical Trials
93 clinical trials
View more details
Mock data
Subscribe for the real data
Indications Phases 4
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
HypertensionD006973EFO_0000537I102415301261
Heart failureD006333EFO_0003144I501326
PrehypertensionD05824633
Coronary artery diseaseD003324I25.122
Left ventricular dysfunctionD018487112
Type 2 diabetes mellitusD003924EFO_0001360E1111
Metabolic syndromeD024821EFO_0000195E88.8111
Arterial pressureD06218611
Chronic obstructive pulmonary diseaseD029424EFO_0000341J44.911
Drug-related side effects and adverse reactionsD064420T88.711
Show 12 more
Indications Phases 3
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Marfan syndromeD008382Orphanet_558Q87.411
Covid-19D000086382U07.111
CardiomyopathiesD009202EFO_0000318I4211
Duchenne muscular dystrophyD02038811
Peripheral arterial diseaseD058729EFO_000426511
Pulmonary arterial hypertensionD00008102911
Breast neoplasmsD001943EFO_0003869C5011
CardiotoxicityD066126EFO_100148211
Large b-cell lymphoma diffuseD016403C83.311
Indications Phases 2
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Ischemic strokeD00008324211
Essential hypertensionD000075222I1011
Myocardial bridgingD05408411
Ocular hypertensionD009798EFO_1001069H40.011
Open-angle glaucomaD005902EFO_0004190H40.111
Indications Phases 1
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Healthy volunteers/patients22
OsteoporosisD010024EFO_0003882M81.011
Idiopathic pulmonary fibrosisD054990J84.11211
Indications Without Phase
Indication
MeSH
Ontology
ICD-10
Ph 1
Ph 2
Ph 3
Ph 4
Other
Total
Atrial fibrillationD001281EFO_0000275I48.011
Exercise testD005080EFO_000432811
Kidney transplantationD01603011
Pure autonomic failureD05497011
Multiple system atrophyD01957811
Epidemiology
Epidemiological information for investigational and approved indications
View more details
Drug
General
Drug common nameNEDOCROMIL
INNnedocromil
Description
Nedocromil is a dicarboxylic acid and an organic heterotricyclic compound. It has a role as a non-steroidal anti-inflammatory drug, an anti-asthmatic drug and an anti-allergic agent. It is a conjugate acid of a nedocromil(2-).
Classification
Small molecule
Drug classantiallergics (cromoglicic acid derivatives)
Image (chem structure or protein)
Structure (InChI/SMILES or Protein Sequence)
CCCc1c2oc(C(=O)O)cc(=O)c2cc2c(=O)cc(C(=O)O)n(CC)c12
Identifiers
PDB
CAS-ID69049-73-6
RxCUI31563
ChEMBL IDCHEMBL746
ChEBI ID7492
PubChem CID50294
DrugBankDB00716
UNII ID0B535E0BN0 (ChemIDplus, GSRS)
Target
Agency Approved
No data
Alternate
No data
Variants
Clinical Variant
No data
Financial
No data
Trends
PubMed Central
Top Terms for Disease or Syndrome:
Mock data
Subscribe for the real data
Additional graphs summarizing 1,578 documents
View more details
Safety
Black-box Warning
No Black-box warning
Adverse Events
Top Adverse Reactions
Mock data
Subscribe for the real data
7,133 adverse events reported
View more details